Financial Results Announcement - CG Oncology, Inc. announced its financial results for the quarter ended June 30, 2024 [6] - The press release detailing the financial results was issued on August 8, 2024 [6] - The press release is attached as Exhibit 99.1 and incorporated by reference [6] Regulatory and Compliance Information - The information in the Form 8-K, including Exhibit 99.1, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act [7] - The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 [5] - The report was signed by Josh Patterson, General Counsel and Chief Compliance Officer of CG Oncology, Inc. [10] Company Classification and Market Information - CG Oncology, Inc. is classified as an emerging growth company [6] - CG Oncology, Inc. is registered on the Nasdaq Global Select Market under the trading symbol CGON [4] Company Contact Information - The company's principal executive offices are located at 400 Spectrum Center Drive, Suite 2040, Irvine, California 92618 [2] - The company's telephone number is (949) 409-3700 [5]
CG Oncology(CGON) - 2024 Q2 - Quarterly Results